文献速递心力衰竭与心肌病瓣膜病与结构性心脏病

心脏磁共振对左心室心肌致密化不全的长期预后价值:一项前瞻性多中心研究

Long-Term Prognostic Value of Cardiac Magnetic Resonance in Left Ventricle Noncompaction: A Prospective Multicenter Study.
PubMed 文献 · J Am Coll Cardiol · 2016-01-01

该研究纳入113例超声诊断左心室心肌致密化不全(LVNC)患者,在5个中心行心脏磁共振(CMR)检查,平均随访48±24个月。结果显示心脏事件发生36例,CMR预测因子为左心室扩张和晚期钆增强(LGE),而左心室小梁化程度无额外预后影响。

要点

  • CMR可评估LVNC患者左心室扩张、收缩功能及LGE,LGE与心脏事件独立相关。
  • 左心室小梁化程度(LV-ncMM>20%等指标)对预后无额外预测价值。
  • 无扩张型心肌病和/或LGE的患者未发生心脏事件。

核心结论

  • 在LVNC患者中,左心室小梁化程度对预后的影响不超过左心室扩张、左心室收缩功能障碍和LGE的存在。

研究设计与样本

  • 前瞻性多中心研究,纳入113例超声诊断LVNC且经CMR确认(非致密/致密比>2.3)的患者,在5个转诊中心行CMR检查。

主要发现

  • 左心室扩张、左心室射血分数受损和LV-ncMM>20%在发生心脏事件的患者中更常见。
  • 11例通过LGE检测到左心室纤维化。
  • CMR预测心脏事件的因子为左心室扩张和LGE,LGE在所有3个模型中均较临床数据和CMR功能参数改善预测。
  • 无扩张型心肌病和/或LGE的患者未发生心脏事件。

关键数值与推荐

  • CMR诊断LVNC标准:舒张末期非致密/致密比>2.3。
  • 分析的LVNC诊断标准包括LV-ncMM>20%和>25%、总LV-ncMM指数>15 g/m2、非致密/致密比≥3:1(AHA模型1-3和7-16节段中≥1个)或≥2:1(4-6节段中至少1个)。

临床怎么用

  • 对于LVNC患者,应关注CMR显示的左心室扩张和LGE,而非仅评估小梁化程度,以进行风险分层。

局限性

  • 样本量较小(113例),事件数有限(36例),可能影响统计效能。
  • 仅纳入超声诊断LVNC的患者,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cardiac magnetic resonance (CMR) is useful for the diagnosis of left ventricular noncompaction (LVNC). However, there are limited data regarding its prognostic value. OBJECTIVES: The goal of this study was to evaluate the prognostic relevance of CMR findings in patients with LVNC. METHODS: A total of 113 patients with an echocardiographic diagnosis of LVNC underwent CMR at 5 referral centers. CMR diagnostic criterion of LVNC (noncompacted/compacted ratio >2.3 in end-diastole) was confirmed in all patients. We performed left ventricular (LV) and right ventricular quantitative analysis and late gadolinium enhancement (LGE) assessments and analyzed the following LVNC diagnostic criteria: left ventricular noncompacted myocardial mass (LV-ncMM) >20% and >25%, total LV-ncMM index >15 g/m2, noncompacted/compacted ratio ≥3:1 ≥1 of segments 1 to 3 and 7 to 16 or ≥2:1 in at least 1 of segments 4 to 6 of the American Heart Association model. Outcome was a composite of thromboembolic events, heart failure hospitalizations, ventricular arrhythmias, and cardiac death. RESULTS: At a mean follow-up of 48 ± 24 months, cardiac events (CEs) occurred in 36 patients (16 heart failure hospitalizations, 10 ventricular arrhythmias, 5 cardiac deaths, and 5 thromboembolic events). LV dilation, impaired LV ejection fraction, and LV-ncMM >20% was significantly more frequent in patients with CEs. LV fibrosis was detected by using LGE in 11 cases. CMR predictors of CEs were LV dilation and LGE. LGE was associated with improved prediction of CEs, compared with clinical data and CMR functional parameters in all 3 models. No CEs occurred in patients without dilated cardiomyopathy and/or LGE. CONCLUSIONS: In patients with LVNC evaluated by using CMR, the degree of LV trabeculation seems to have no prognostic impact over and above LV dilation, LV systolic dysfunction, and presence of LGE.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Andreini D, Pontone G, Bogaert J, et al. Long-Term Prognostic Value of Cardiac Magnetic Resonance in Left Ventricle Noncompaction: A Prospective Multicenter Study. J Am Coll Cardiol. 2016. PMID: 27855806. doi:10.1016/j.jacc.2016.08.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。